Race Oncology Limited (RAONF)
USD 1.22
(0.0%)
USD 1.22
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -13.81 Million AUD | -39.26% |
| 2023 | -9.92 Million AUD | 14.5% |
| 2022 | -7.72 Million AUD | -62.39% |
| 2021 | -4.75 Million AUD | -79.76% |
| 2020 | -2.64 Million AUD | -3.11% |
| 2019 | -2.56 Million AUD | 44.89% |
| 2018 | -4.65 Million AUD | -45.62% |
| 2017 | -3.19 Million AUD | -1251.82% |
| 2016 | -236.7 Thousand AUD | -252.43% |
| 2015 | -67.16 Thousand AUD | 22.9% |
| 2014 | -87.11 Thousand AUD | -837.81% |
| 2013 | -9289.15 AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -5.43 Million USD | 0.0% |
| 2024 Q2 | -3.85 Million USD | 0.0% |
| 2023 Q4 | -3.67 Million USD | 0.0% |
| 2023 FY | -6.6 Million AUD | 14.5% |
| 2023 Q2 | -3 Million USD | 0.0% |
| 2022 Q2 | -3.49 Million USD | 0.0% |
| 2022 FY | -7.72 Million AUD | -62.39% |
| 2022 Q4 | -4.4 Million USD | 0.0% |
| 2021 Q4 | -3.21 Million USD | 0.0% |
| 2021 FY | -4.75 Million AUD | -79.76% |
| 2021 Q2 | -1.58 Million USD | 0.0% |
| 2020 Q4 | -1.61 Million USD | 0.0% |
| 2020 Q2 | -1.05 Million USD | 0.0% |
| 2020 FY | -2.64 Million AUD | -3.11% |
| 2019 FY | -2.56 Million AUD | 44.89% |
| 2019 Q4 | -1.14 Million USD | 0.0% |
| 2018 FY | -4.65 Million AUD | -45.62% |
| 2017 FY | -3.19 Million AUD | -1251.82% |
| 2016 FY | -236.7 Thousand AUD | -252.43% |
| 2015 FY | -67.16 Thousand AUD | 22.9% |
| 2014 FY | -87.11 Thousand AUD | -837.81% |
| 2013 FY | -9289.15 AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 81.565% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -110.145% |
| SQZ Biotechnologies Company | -79.46 Million USD | 82.609% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 126.085% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 121.217% |
| Mesoblast Limited | -87.95 Million USD | 84.288% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -659.084% |
| Genus plc | 7.9 Million USD | 274.928% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -26.879% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -272.465% |
| Marizyme, Inc. | -65.34 Million USD | 78.852% |
| ContraFect Corporation | -65.15 Million USD | 78.789% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -56.257% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -182.832% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -699.982% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -377.782% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -71.463% |
| MultiCell Technologies, Inc. | -380.07 USD | -3635897.579% |
| Accustem Sciences Inc. | -3.74 Million USD | -268.868% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 73.266% |
| EV Biologics, Inc. | -1.26 Million USD | -990.598% |
| Q BioMed Inc. | -2.05 Million USD | -573.426% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -270.194% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -2085.197% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -480.432% |
| Biomind Labs Inc. | -1.21 Million USD | -1038.032% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | -31.014% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -74.86% |
| Skye Bioscience, Inc. | -37.64 Million USD | 63.29% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -536.89% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -92176.549% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -97.904% |
| IMV Inc. | -36.48 Million USD | 62.124% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 12.93% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -137.558% |
| GB Sciences, Inc. | -1.36 Million USD | -914.876% |
| Alpha Cognition Inc. | -13.77 Million USD | -0.34% |
| HST Global, Inc. | -146.21 Thousand USD | -9351.704% |
| CSL Limited | 2.64 Billion USD | 100.523% |
| Halberd Corporation | -79.67 Thousand USD | -17244.415% |
| Enzolytics Inc. | -2.17 Million USD | -534.837% |
| Resverlogix Corp. | -3.61 Million USD | -282.807% |
| Affymax, Inc. | -14.42 Million USD | 4.192% |
| SYBLEU INC | -180.3 Thousand USD | -7564.464% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -335.744% |
| argenx SE | -295.05 Million USD | 95.316% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 77.924% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 14201.363% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -247.832% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -356.666% |
| AVAX Technologies, Inc. | -6.41 Million USD | -115.468% |
| Zenith Capital Corp. | -10.59 Million USD | -30.42% |
| Genscript Biotech Corporation | -95.47 Million USD | 85.526% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -59358.463% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -233.322% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -22764.323% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 76.862% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -345.531% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -1208.579% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -608.957% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -261.857% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -589.204% |
| BioStem Technologies, Inc. | -8.48 Million USD | -62.907% |
| ONE Bio Corp. | 8.67 Million USD | 259.271% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -3031.016% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -934.822% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -687.529% |
| Agentix Corp. | -1.37 Million USD | -905.62% |
| LadRx Corporation | 400.44 Thousand USD | 3551.012% |
| Cell Source, Inc. | -5.32 Million USD | -159.703% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -3226.121% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1450.193% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1450.193% |
| NovAccess Global Inc. | -4.76 Million USD | -189.763% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 299.569% |
| Itoco Inc. | -1.86 Million USD | -639.399% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -211.069% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -728.001% |
| Kadimastem Ltd | -3.3 Million USD | -317.831% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -4954.585% |
| CytoDyn Inc. | -49.84 Million USD | 72.273% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -17385.526% |
| Mobile Lads Corp. | -2.26 Million USD | -510.586% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -5957.738% |
| Qrons Inc. | -789.34 Thousand USD | -1650.73% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -1367.755% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -561.946% |
| Rebus Holdings, Inc. | -1.02 Million USD | -1254.837% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -756.887% |
| International Stem Cell Corporation | -131 Thousand USD | -10449.111% |
| Bioxytran, Inc. | -4.28 Million USD | -222.882% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -25363.104% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -446.165% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 71.253% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -553.706% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -1669.697% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -336.216% |
| Neutra Corp. | -233.46 Thousand USD | -5819.232% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 31.894% |
| PureTech Health plc | -65.69 Million USD | 78.965% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 35.018% |
| IXICO plc | -1.17 Million USD | -1073.119% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -39.21% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 75.81% |
| CSL Limited | 2.64 Billion USD | 100.523% |
| Cellectis S.A. | -103.17 Million USD | 86.606% |